Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Connective and Soft Tissue Neoplasm — Research · CancerIndex

Cancers
Neoplasm
Neoplasm by Site
Connective and Soft Tissue Neoplasm

Cancer Family

Connective and Soft Tissue Neoplasm

CI-CAN-00000010Explore in graph →

Non-malignant848 active trials17 approved drugs339 evidence items

NCIt: C3810
MeSH: D018204

Overview
Statistics
Survival
Genomics24
Variants & evidence339
Drugs43
Trials3876
Research
Rankings
Sources & provenance

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Trials tab
Methodology: publication counts

Literature

Linked publications (225)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedProvenance

Source: PubMed (NLM)
Dataset: PubMed E-utilities
Retrieved: Sep 29, 2026
Layer: normalized (units and labels harmonized; values unchanged)

PublishedShowing 1–25 of 225 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Kaposi Sarcoma Herpesvirus (KSHV) Subtypes and Impact on Outcomes in KSHV-Associated Diseases.
Jose Mercado Matos, Vickie A Marshall, Elena M Cornejo Castro et al. · J Infect Dis · Sep 23, 2026 · PMID 41845569 · candidate dictionary pubmed
The many facets of Kaposi sarcoma-associated herpesvirus/human herpes virus-8 multicentric Castleman disease: clinical spectrum, diagnostic innovations, and therapeutic management.
David Boutboul, Romain Stammler, Yannick Dieudonné · Curr Opin Oncol · Sep 1, 2026 · PMID 42570341 · candidate dictionary pubmed
A case of endemic Kaposi sarcoma mimicking morphea.
Dikra Suleyman George, Bizuayehu Goshime Haile, Edelawit Yitna Mengesha et al. · JAAD Case Rep · Sep 1, 2026 · PMID 42699303 · candidate dictionary pubmed
Evolving understanding of Kaposi sarcoma and associated diseases in the ART era.
Nazzarena Labo, Elena M Cornejo Castro, Vickie A Marshall et al. · Lancet HIV · Sep 1, 2026 · PMID 42561985 · candidate dictionary pubmed
Diagnostic concordance and delayed recognition: a case of atypical Kaposi sarcoma.
Hunter Cohn, Jeannie Hennessy, Kaitlin Schupp et al. · Diagnosis (Berl) · Aug 11, 2026 · PMID 42572821 · candidate dictionary pubmed
Classic lymphangioma-like Kaposi sarcoma in an HIV-negative elderly patient.
Vinz Troy Manuel Solanoy, Eileen Liesl Abesamis Cubillan · BMJ Case Rep · Aug 10, 2026 · PMID 42575683 · candidate dictionary pubmed
Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor.

Showing 1–25 of 225 publications

← Previous
1
2
…
9
Next →

· J Clin Oncol · 2003 · PMID 14645423 · validated civic_curation pubmed

Fusions of the SYT and SSX genes in synovial sarcoma.

· Oncogene · 2001 · PMID 11607825 · validated civic_curation pubmed

KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours.

· Eur J Cancer · 2006 · PMID 16624552 · validated civic_curation pubmed

Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study.

· Lancet Oncol · 2018 · PMID 29606586 · validated civic_curation pubmed

A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma.

· Nat Genet · 1998 · PMID 9462753 · validated civic_curation pubmed

Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study.

· J Clin Oncol · 2017 · PMID 28787259 · validated civic_curation pubmed

Larotrectinib in adult patients with solid tumours: a multi-centre, open-label, phase I dose-escalation study.

· Ann Oncol · 2019 · PMID 30624546 · validated civic_curation pubmed

Long-term effects of crizotinib in ALK-positive tumors (excluding NSCLC): A phase 1b open-label study.

· Am J Hematol · 2018 · PMID 29352732 · validated civic_curation pubmed

Integrated multimodal genetic testing of Ewing sarcoma--a single-institution experience.

· Hum Pathol · 2013 · PMID 23706910 · validated civic_curation pubmed

Recurrent internal tandem duplications of BCOR in clear cell sarcoma of the kidney.

· Nat Commun · 2015 · PMID 26573325 · validated civic_curation pubmed

PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib.

· J Clin Oncol · 2005 · PMID 15928335 · validated civic_curation pubmed

Molecular correlates of imatinib resistance in gastrointestinal stromal tumors.

· J Clin Oncol · 2006 · PMID 16954519 · validated civic_curation pubmed

EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma.

· J Clin Oncol · 1998 · PMID 9552022 · validated civic_curation pubmed

Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.

· Pharmacogenomics J · 2009 · PMID 19434073 · validated civic_curation pubmed

Efficacy of Imatinib in Patients with Platelet-Derived Growth Factor Receptor Alpha-Mutated Gastrointestinal Stromal Tumors.

· Cancer Res Treat · 2016 · PMID 26130666 · validated civic_curation pubmed

Diagnostic gold standard for soft tissue tumours: morphology or molecular genetics?

· Histopathology · 2000 · PMID 11122430 · validated civic_curation pubmed

Malignant peripheral nerve sheath tumors with t(X;18). A pathologic and molecular genetic study.

· Mod Pathol · 2000 · PMID 11144931 · validated civic_curation pubmed

Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.

· Cancer Res · 2002 · PMID 11782370 · validated civic_curation pubmed

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.

· Lancet Oncol · 2013 · PMID 23598171 · validated civic_curation pubmed